Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hyundai Motor (005380) – Decision on Cash and In-Kind Dividend / 2025-01-23 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Decision on Cash and Property Dividend / 2025-07-24 Disclosures
  • [Disclosure] Celltrion (068270) – Notice of Ex-Dividend Reference Price / 2024-12-26 Disclosures
  • [Disclosure] LEENO Industrial (058470) – Decision on Cash/In-Kind Dividend / 2024-12-19 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Decision on Paid-in Capital Increase / 2026-03-04 Disclosures
  • [Disclosure] HPSP (403870) – Execution of Stock Pledge Agreement Involving Change of Largest Shareholder / 2025-05-16 Semiconductors
  • [Disclosure] Samsung Electronics(005930) – Decision on Cash and In-Kind Dividend / 2024-01-31 Disclosures
  • [Disclosure] Hana Micron (067310) – Ex-Rights (Bonus Issue) / 2024-08-07 Semiconductors

Category: Disclosures

[Disclosure] Hyundai Motor (005380) – Status of Compliance Program Operation / 2026-07-23

Posted on July 23, 2026August 11, 2026 By K-STOCK Editor
[Disclosure] Hyundai Motor (005380) – Status of Compliance Program Operation / 2026-07-23

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hyundai Motor Company disclosed its Q2 2026 Fair Trade Compliance Program (CP) operating performance and Q3 plans, following a report to its Sustainability Management Committee. 📊 [Key Disclosure Details & Financial Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Execution of Q3 Plans and Progress on…

Read More “[Disclosure] Hyundai Motor (005380) – Status of Compliance Program Operation / 2026-07-23” »

Disclosures, Automotive

[Disclosure] Samsung Biologics (207940) – Consolidated Financial Results (Preliminary) / 2026-07-23

Posted on July 23, 2026August 7, 2026 By K-STOCK Editor
[Disclosure] Samsung Biologics (207940) – Consolidated Financial Results (Preliminary) / 2026-07-23

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics reported Q2 2026 consolidated revenue of KRW 1.32T and operating profit of KRW 586.4B, marking a year-over-year increase of 30.2% and 22.9%, respectively. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of External Auditor’s Review and Final…

Read More “[Disclosure] Samsung Biologics (207940) – Consolidated Financial Results (Preliminary) / 2026-07-23” »

Disclosures, Bio & Healthcare

[Disclosure] SK Square (402340) – Decision on Stock Retirement / 2026-07-22

Posted on July 22, 2026July 30, 2026 By K-STOCK Editor
[Disclosure] SK Square (402340) – Decision on Stock Retirement / 2026-07-22

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square resolved to retire 34,388 shares of previously acquired common treasury stock (estimated retirement value of approx. KRW 43.09B) on July 31, 2026. 📊 [Summary of Key Disclosure Facts & Figures] 1. Stock Retirement Details 2. Retirement Method & Schedule 3. Other Key Investment Notes…

Read More “[Disclosure] SK Square (402340) – Decision on Stock Retirement / 2026-07-22” »

Disclosures, Semiconductors

[Disclosure] SK Square (402340) – New Facility Investment / 2026-07-22

Posted on July 22, 2026July 31, 2026 By K-STOCK Editor
[Disclosure] SK Square (402340) – New Facility Investment / 2026-07-22

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary SK Square’s major subsidiary, SK Hynix, resolved to increase its capital investment for the construction of Cheongju P&T7 to KRW 7.0931T (5.88% of equity) to address global AI memory demand. 📊 [Summary of Key Disclosure Facts & Figures] 1. Investment Overview & Type 2. Investment Details…

Read More “[Disclosure] SK Square (402340) – New Facility Investment / 2026-07-22” »

Disclosures, Semiconductors

[Disclosure] SK Hynix (000660 / SKHY) – Clarification Regarding Rumors or Reports / 2026-07-22

Posted on July 22, 2026August 11, 2026 By K-STOCK Editor
[Disclosure] SK Hynix (000660 / SKHY) – Clarification Regarding Rumors or Reports / 2026-07-22

Fact Source: Financial Supervisory Service DARTMarket: KOSPI (000660) 💡 3-Second Summary In response to a media report claiming that SK Hynix is acquiring Intel’s Ohio plant in the U.S., the company officially clarified that it has neither pursued nor decided on such an acquisition. 📊 [Key Summary & Financial Figures] 📝 Editor’s Comment (Key Follow-up…

Read More “[Disclosure] SK Hynix (000660 / SKHY) – Clarification Regarding Rumors or Reports / 2026-07-22” »

Disclosures, Semiconductors

[Disclosure] SK Hynix (000660 / SKHY) – New Facility Investment / 2026-07-22

Posted on July 22, 2026August 11, 2026 By K-STOCK Editor
[Disclosure] SK Hynix (000660 / SKHY) – New Facility Investment / 2026-07-22

Fact Source: Financial Supervisory Service DARTMarket: KOSPI (000660) 💡 3-Second Summary SK Hynix has decided to invest a total of KRW 7.09T in the construction of Cheongju P&T7 to secure a production base responding to global AI memory demand. 📊 [Key Summary & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verifying Progress and…

Read More “[Disclosure] SK Hynix (000660 / SKHY) – New Facility Investment / 2026-07-22” »

Disclosures, Semiconductors

[Disclosure] Hanmi Semiconductor (042700) – Corporate Value-up Plan (Voluntary Disclosure) / 2026-07-20

Posted on July 20, 2026July 31, 2026 By K-STOCK Editor
[Disclosure] Hanmi Semiconductor (042700) – Corporate Value-up Plan (Voluntary Disclosure) / 2026-07-20

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanmi Semiconductor unveiled its corporate value-up plan, detailing business roadmaps for next-generation semiconductor equipment, establishing a U.S. subsidiary, and implementing tax-exempt dividend policies. 📊 [Summary of Key Disclosure Content and Major Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Next-Generation Equipment Release Schedule and U.S. Subsidiary…

Read More “[Disclosure] Hanmi Semiconductor (042700) – Corporate Value-up Plan (Voluntary Disclosure) / 2026-07-20” »

Disclosures, Semiconductors

[Disclosure] Daeduck Electronics (353200) – New Facility Investment / 2026-07-20

Posted on July 20, 2026August 3, 2026 By K-STOCK Editor
[Disclosure] Daeduck Electronics (353200) – New Facility Investment / 2026-07-20

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Daeduck Electronics decided to invest KRW 497.0B, equivalent to 55.39% of its equity, in new semiconductor manufacturing equipment and auxiliary facilities to meet growing market demand. 📊 Key Disclosure Contents & Major Figures 1. Investment Purpose and Scope 2. Investment Amount and Equity Ratio 3. Investment…

Read More “[Disclosure] Daeduck Electronics (353200) – New Facility Investment / 2026-07-20” »

Disclosures, Semiconductors

[Disclosure] ALTEOGEN (196170) – (Correction) Decision on Bonus Issue / 2026-07-20

Posted on July 20, 2026August 5, 2026 By K-STOCK Editor
[Disclosure] ALTEOGEN (196170) – (Correction) Decision on Bonus Issue / 2026-07-20

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ALTEOGEN submitted a correction disclosure updating the expected listing date of new shares for its bonus issue from August 20, 2026, to August 26, 2026, following consultations with relevant authorities. 📊 [Key Disclosure Details & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification…

Read More “[Disclosure] ALTEOGEN (196170) – (Correction) Decision on Bonus Issue / 2026-07-20” »

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2026-07-20

Posted on July 20, 2026August 7, 2026 By K-STOCK Editor
[Disclosure] Samsung Biologics (207940) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2026-07-20

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has decided to acquire 33,016,411 shares of PolyPeptide Group AG, a Swiss peptide CDMO specialist, for approximately KRW 2.71T through a tender offer to strengthen its business competitiveness. 📊 [Key Disclosure Details & Financial Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Satisfaction of…

Read More “[Disclosure] Samsung Biologics (207940) – Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2026-07-20” »

Disclosures, Bio & Healthcare

Posts pagination

Previous 1 … 5 6 7 … 252 Next
  • [Disclosure] SK hynix (000660 / SKHY) – Investor Relations (IR) Holding (Information Disclosure) / 2025-07-09 Semiconductors
  • [Research] Samsung Electro-Mechanics (009150) – SK Securities | MLCC Utilization Recovery · AI Accelerator Substrates · North American Big Tech / 2025-08-01 RESEARCH
  • [Disclosure] Hanwha Systems (272210) – Execution of Single Sales or Supply Contract / 2026-04-20 Disclosures
  • [Disclosure] Hanwha Systems (272210) – (Correction) Decision on Acquisition of Shares and Investment Certificates in Other Corporations / 2025-12-23 Disclosures
  • [Disclosure] Jusung Engineering (036930) – Change of Chief Executive Officer (CEO) / 2025-09-19 Semiconductors
  • [Disclosure] Celltrion (068270) – Additional Listing (Stock Option Exercise) / 2024-05-09 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Resolution on Convocation of General Meeting of Shareholders / 2026-08-04 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Decision on Early Acquisition of Own Exchangeable Bonds / 2026-04-28 Semiconductors

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme